Search Results - Cafoncelli, S.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52‐week results from a Phase 3 double‐blind randomized, controlled trial

    Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52‐week results from a Phase 3 double‐blind rand... by Bodemer, C., Kaszuba, A., Kingo, K., Tsianakas, A., Morita, A., Rivas, E., Papanastasiou, P., Keefe, D., Patekar, M., Charef, P., Zhang, L., Cafoncelli, S., Papavassilis, C.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

    A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years by Reid, Ian R, Lyles, Kenneth, Su, Guoqin, Brown, Jacques P, Walsh, John P, del Pino‐Montes, Javier, Miller, Paul D, Fraser, William D, Cafoncelli, Susan, Bucci‐Rechtweg, Christina, Hosking, David J

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A Single Infusion of Zoledronic Acid Produces Sustained Remissions in Paget Disease: Data to Years

    A Single Infusion of Zoledronic Acid Produces Sustained Remissions in Paget Disease: Data to Years by Reid, IR, Lyles, K, Su, G, Brown, J P, Walsh, J P, del Pino-Montes, J, Miller, P D, Fraser, W D, Cafoncelli, S, Bucci-Rechtweg, C, Hosking, D J

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: